Avid Bioservices Inc (CDMO)

[jbainseky]

No it doesn't CP -

So in his mind he seemed to think that a specific sub-group triggered the DMC advice and he apparently did not start from the assumption that the complete trial was the cause. It PROVES that sub-groups were in any case defined UP-FRONT at trial design, just as Shan said before on a Q/CC and were approved by the FDA

All King was saying is PPHM was going to analyze the data to determine if any subgroups substantially performed in BAVI's favor, or the reverse, if any subgroup caused BAVI to under-perform. the subgroups were not defined upfront. This is clear because he said subgroups or patient characteristics and they would not have stipulated patient characteristics up front.

You are jumping to unsubstantiated conclusions when you say that your interpretation "PROVES" something.

FFTT

JBAIN